Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dysautonomic Signs Among MECP2boys

NCT04502199 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04502199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dysautonomic Signs Among MECP2boys
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Unknown status
Start date
August 15, 2020
Completion date
January 13, 2021
Enrollment
20 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

dysautonomia, masculinity, mecp2-related severe neonatal encephalopathy